Population Council, Nairobi, Kenya.
International Planned Parenthood Federation, London, United Kingdom.
Glob Health Sci Pract. 2018 Dec 27;6(4):711-722. doi: 10.9745/GHSP-D-18-00117.
Reproductive Health Uganda (RHU), a local NGO, introduced subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana Press) in 4 districts of Uganda between April 2016 and March 2017. RHU trained public and private facility providers on all family planning methods including DMPA-SC; trained community health workers (known as village health teams, VHTs) to give family planning counseling, provide short-acting methods including DMPA-SC, and make referrals for long-acting and permanent methods; conducted mobile outreach and raised awareness of family planning; and provided family planning commodities. We used a retrospective cross-sectional evaluation design drawing on data from (1) in-depth interviews with 32 facility- and community-based providers; (2) key informant interviews with 7 policy makers and program staff; and (3) family planning program statistics from 4 RHU clinics, 26 mobile outreach sites, and 40 VHTs in 4 study districts. Data collection took place between April and June 2017. Over 12 months, 14,273 units of DMPA-SC were provided in RHU clinics, by mobile outreach teams, and by VHTs. DMPA-SC units were mostly administered in community settings either by VHTs (70%) or at mobile outreach events (26%). A substantial proportion (43%) of DMPA-SC units were administered to young people (<25 years), a significantly higher proportion compared with other methods provided to this age group through the project (<.001), except condoms. In addition, a greater proportion of DMPA-SC units provided at the community level by VHTs were used by young people (45%) compared with units provided at outreach (36%) or in clinics (35%). Overall, injectables (DMPA-SC and intramuscular DMPA combined) came to represent 43% of all contraceptive methods provided, up from a baseline of 20%. This shift occurred despite significant increases in the volume of all other methods provided (<.001). Qualitative data revealed various factors that facilitated introduction, including comprehensive training, commodity availability, strong referral links, and early community engagement. RHU's experience supports the viability of community-based delivery of DMPA-SC and identifies opportunities to strengthen this approach. There is further evidence that DMPA-SC may be popular with young people, especially in community settings.
生殖健康联盟(Reproductive Health Uganda,简称 RHU)于 2016 年 4 月至 2017 年 3 月期间在乌干达的 4 个地区引入了皮下注射型醋酸甲羟孕酮(Depot medroxyprogesterone acetate,DMPA-SC,商品名为 Sayana Press)。RHU 对所有计划生育方法(包括 DMPA-SC)对公共和私人医疗机构的提供者进行了培训;培训社区卫生工作者(称为村卫生团队,VHT)提供计划生育咨询、提供包括 DMPA-SC 在内的短效方法,并为长效和永久性方法提供转诊;开展流动外展活动,提高计划生育意识;提供计划生育用品。我们使用了回顾性的横断面评估设计,从(1)对 32 名医疗机构和社区提供者的深入访谈;(2)对 7 名政策制定者和项目工作人员的关键信息访谈;(3)来自 4 个 RHU 诊所、26 个流动外展点和 40 个 VHT 的计划生育项目统计数据。数据收集于 2017 年 4 月至 6 月期间进行。在 12 个月期间,RHU 诊所、流动外展队和 VHT 提供了 14273 单位的 DMPA-SC。DMPA-SC 单位主要由 VHT(70%)或在流动外展活动中(26%)在社区环境中管理。相当一部分(43%)的 DMPA-SC 单位用于年轻人(<25 岁),与该年龄组通过该项目提供的其他方法(<.001)相比,这一比例明显更高,除了避孕套。此外,由 VHT 在社区一级提供的 DMPA-SC 单位中,年轻人(45%)使用的比例高于在流动外展(36%)或诊所(35%)提供的比例。总的来说,注射剂(DMPA-SC 和肌肉内注射型 DMPA 合并)在所有提供的避孕方法中占比达到了 43%,高于基线时的 20%。尽管所有其他提供的方法的数量都显著增加(<.001),但这一转变还是发生了。定性数据揭示了促进引入的各种因素,包括全面的培训、商品的可用性、强有力的转诊联系以及早期的社区参与。RHU 的经验支持了 DMPA-SC 在社区层面的可行性,并确定了加强这一方法的机会。进一步的证据表明,DMPA-SC 可能受到年轻人的欢迎,尤其是在社区环境中。